Header Logo


Mahdi Garelnabi to Cardiovascular Diseases

This is a "connection" page, showing publications Mahdi Garelnabi has written about Cardiovascular Diseases.
Connection Strength

  1. Punch E, Klein J, Diaba-Nuhoho P, Morawietz H, Garelnabi M. Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis. J Am Heart Assoc. 2022 02; 11(3):e023328.
    View in: PubMed
    Score: 0.570
  2. McGrail L, Garelnabi M. Polyphenolic Compounds and Gut Microbiome in Cardiovascular Diseases. Curr Pharm Biotechnol. 2020; 21(7):578-586.
    View in: PubMed
    Score: 0.494
  3. Garelnabi M, Lor K, Jin J, Chai F, Santanam N. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research. Clin Biochem. 2013 Jan; 46(1-2):12-9.
    View in: PubMed
    Score: 0.298
  4. Garelnabi M, Veledar E, Abramson J, White-Welkley J, Santanam N, Weintraub W, Parthasarathy S. Physical inactivity and cardiovascular risk: baseline observations from men and premenopausal women. J Clin Lab Anal. 2010; 24(2):100-5.
    View in: PubMed
    Score: 0.247
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.